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Funiculosin is a well-known inhibitor of the mitochondrial respiratory chain, probably acting at the ubiquinone reducing site or center i of Q&- 
cytochrome c reductase. We report here the isolation, mapping and RNA sequence analysis of yeast apo-cytcchrome b mutants resistant o this 
inhibitor. Funiculosin-resistance was found to be conferred, in 4 independent isolates, upon replacement of a leucine residue by phenylalanine in 
position 198 of the cytochrome bpolypeptide chain. 
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1. INTRODUCTION 
In the mitochondrial respiratory chain, the 
QHz-cytochrome c reductase (bci complex) transfers 
electrons from ubiquinol to cytochrome c, which is 
coupled to the electrogenic translocation of protons 
across the mitochondrial inner membrane [1,2]. The 
bci complex from S. cerevisiae consists of 9 polypep- 
tides, 3 of which have known electron transfer func- 
tions (cytochrome b, cytochrome cl and the Rieske FeS 
protein). Apo-cytochrome b is encoded by the 
mitochondrial DNA, while all the other subunits are of 
nuclear origin. 
stigmatellin [12] were localized in the split mitochon- 
drial gene coding for apo-cytochrome b (gene COB- 
BOX) [8,13-B]. The RNA sequence analysis of more 
than 30 of them revealed that inhibitor-resistance was 
conferred upon replacement at a few positions of the 
cytochrome b polypeptide chain [ 12,16,17]. These 
results have important implications concerning the 
cytochrome b structure in the membrane and define 
regions of the protein which might belong to the 
quinone reaction domains of the bci complex. 
The electron transfer from ubiquinol to cytochrome 
c is best described in terms of a proton motive Q-cycle 
mechanism [3]. This implies that cytochrome b would 
be responsible for a transmembrane lectron transfer 
between two ubiquinone oxidoreduction centers, these 
are referred to as center o and center i, and are located 
near the electropositive and electronegative side of the 
membrane. 
We report here the isolation, mapping and RNA se- 
quence analysis of yeast apo-cytochrome b mutants 
resistant o the center i inhibitor funiculosin. Resistance 
to this inhibitor was found to be conferred upon 
replacement of a leucine residue by phenylalanine in 
position 198 of the cytochrome b polypeptide chain. 
2. MATERIALS AND METHODS 
2.1. Strains 
Several organic compounds, most of which are 
naturally produced by bacteria, inhibit cytochrome Zr 
oxidoreduction (see [4] for review). Antimycin, 
funiculosin and diuron are thought to exert their action 
at center i, while myxothiazol, mucidin (or strobilurin 
A) and stigmatellin would block center o. 
2.1.1. Wild type strains 
KL14-4A, a his1 trp2 olil-I capl-321 parl-454; D273-lOB/A21, 
alpha met olil-625 ery3-624 parl-626; D8-22A alpha his4 ade2; 
D225-5A, alpha adel lys2. 
Numerous yeast mutants resistant o antimycin [5,6], 
diuron [7], myxothiazol [S], mucidin [9-l l] and 
2.1.2. Resistant mutants 
Mucidin [lO,ll]: D225-5A/3D mucl-771; K50-15B Ural 
muc3-K50-I5B. D225-5A/lOl-4B muc2-772; diuron [13]: 
D273-lOB/A21 diul-724; antimycin [5]: DS-22A/G25 ana2-G25. 
2.1.3. rho- strain 
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2.2. Media 
YPlO: 10% glucose, 1% yeast extract, 1% bacto peptone (Difco); 
YPGA: 2010 glucose, 1% yeast extract, 1% bacto peptone, 10 mg/l of 
adenine; N3: 2% glycerol, 1% yeast extract, 1% bacto peptone. Solid 
media contained 2% agar. Inhibitors were added as ethanolic solu- 
tion to agar-containing media in surfusion at 50°C before solidifica- 
tion to the following final concentrations: diuron, 1OOrM; 
myxothiazol, 1.5 pg/ml; mucidin, 0.3 ,ug/ml; funiculosin, 5 /g/ml; 
antimycin, 0. I rg/ml. 
2.3. Chemicals and genetic method 
Standard genetic methods were as described in ]13]. Antimycin and 
myxothiazol were purchased from Boehringer. Diuron 
3-(3,Cdichlorophenyl)-1,1-dimethylurea, w s obtained from E.I. Du 
Pont de Nemours. Mucidin and funiculosin were gifts from J. Subik 
(Food Research Institute, Bratislava, Czechoslovakia) and M. Bri- 
quet (Laboratoire de I’HCrediti! Cytoplasmique, Louvain-la-Neuve, 
Belgium), respectively. 
2.4. Isolation of the funiculosin-resistant mutants 
A YPlO culture of the wild type strain KL14-4A was plated out for 
single colonies on YPGA. Individual subclones picked up at random 
were grown in YPlO and then plated on N3 supplemented with 
5 pg/ml of funiculosin at a density of about 5 x 10s cells per plate. 
Each subclone produced a different amount of funiculosin-r~ist~t 
colonies after a 5-lo-day incubation at 28°C. Some subciones did 
not give any drug-resistant clone at all. Only one’mumnt from each 
parental strain subclone was retained for further analysis. The 
mutants were subcloned on YPGA and checked for funiculosin 
resistance. 
2.5. Isolation of mito~hondria and respi~tory activity 
measurements 
These were as described in [ 181. 
2.6. RNA sequencing 
Mitochondrial RNA extraction and RNA sequencing were as 
described in [17]. 
3. RESGLTS 
Spontaneous mutants exhibiting resistance to 
funiculosin have been isolated from strain KL14-4A on 
glycerol in the presence of 5 pg/ml of funiculosin, in 
such a way as to be certain that they resulted from in- 
dependent mutational events (see section 2 for pro- 
cedure). The parental strain KL14-4A possesses the 
long version of the split mitochondrial cytochrome b 
gene (COB-BOX gene) which is 7172 bp long and con- 
tains 6 exons, the sizes of which range from 14 to 
415 bp. 
Mutants arising from a mutational event modifying 
the control of the cell permeability were identified by 
their increased tolerance to cycloheximide as described 
in [19]. Among 40 isolates, 36 were resistant up to 
1 pglml of cycloheximide. Four mutants, KL14-4A/ 
f~~~-ZlO, KLl4~A/fun~-226, KL14-4A/funf-232 and 
KL14-4A/funZ-236 had a cycloheximide sensitivity 
similar to the wild type (complete growth inhibition at 
0.1 pg/ml). 
The genetic mapping of the funiculosin- 
resistant/cyclohe~mide-sensitive mutants has been per- 
formed as described in [ 131. It revealed that all 4 muta- 
tions were within the cytochrome b gene. Indeed, in 
crosses between the fun mutants and the rho- strain 
D273-lOB/A21/Rll (see section 2) carrying the wild 
type cytochrome b gene, sensitive recombinants were 
found at a frequency fluctuating between 35 and 45%, 
indicating the presence of the wild type allele of the fun 
mutations in the cytochrome b gene. 
Allelism tests have been performed between the fun 
mutations and 5 COB-BOX inhibitor-resistant markers 
whose exact positions were determined previously 
112,171: the mucidin-resist~t mutations ~~~~-771 
(Glyi37-Arg, in exon Bl), mud-1YSO-l5B (Asnzsa-Tyr, 
in exon B5) and muc2-772 (Leu27s-Ser, in exon B6), the 
diuron-resistant mutation diul-724 (Phezzs-Ser, in exon 
B4) and the antimycin-resistant mutation ana2-G2.5 
(Lys22s-Met, in exon B4). The frequency of double- 
sensitive r~ombin~ts was below 0.5% when the 
funiculosin-resistant mutants were crossed with the 
diuron- and antimycin-resistant mutants (see Table I). 
When crossed with the mucidin-resistant mutants, 
double-sensitive recombinants appeared at a frequency 
of 2% with muc2-772 and muc3-K50-ISB and of 10% 
with mu&771. A high bias in parental phenotype 
transmission occurred with muc2- 772 and 
Table I 
Allelism tests between funiculosin-resistant and various cytochrome b inhibitor-resistant 
mutants 
mucl-771 ana2-G25 diul-724 mud-KSO-15B muc2-772 
funl-210 22’: 191b:2.6C 0: 193:0.5 1:200:0.9 6: 199:3.1 4:199:31.3 
funl-226 19 :I99 :1.9 0:200:0.8 0:198:1.6 4:200:3.2 3:200:26,2 
funl-232 16 :1% :I.8 0:198:0.6 0:199:1.0 3:200:3.2 2: 100:23.5 
funl-236 22 :2OO :1.7 0:198:0.6 0: 198:O.g 4: 197:2.4 3:100:31.6 
a Number of double sensitive recombinants 
b Total colonies tested 
’ Parental phenotype ratio (Fun’Drug’/Fun”Drug 
The funiculosin-resistant mutations were first shown to belong to the cytochrome b gene. 
Their locations within the cytochrome b gene were then probed by allelism tests with 5 
cytochrome b resistant markers of known position (see text for further details). fun, 
funiculosin; diu, diuron; ana, antimycin; muc, mucidin 
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Fig. 1. Effect of funiculosin on NADH oxidation of wild type and 
funiculosin-resistant mutant mitochondria. The protein 
concentration was 0.185 mg/ml for strain KL14-4A (a) and 
0.33 mg/ml for mutant KL14-4A/funl-210 (0). Mitochondria were 
preincubated in the presence of funiculosin and 0.5 PM CCCP for 
4 min before starting the reaction with the addition of NADH to a 
2 mM final concentration. Control respiration rate (nmol Oz/min per 
mg) was 102 for the wild type and 150 for the mutant. 
muc3-K50-15B (ratio between parental phenotypes, 
FunTMucS/FunSMucr, of about 25 and 3, respectively, 
see Table I). Thus, recombination frequency with these 
tester markers was largely underestimated. 
Surprisingly, no double-resistant recombinant 
FunTMucr was present in the crosses between the 
funiculosin- and the mucidin-resistant mutants (data 
not shown). One explanation could be that such a 
recombinant is respiratory deficient. By contrast, some 
rare double-resistant recombinants AnaW_m’ and 
Diu’Fun’ were observed when the funiculosin-resistant 
mutants were crossed with the antimycin- and diuron- 
resistant mutants. 
The allelism tests indicated that the funiculosin- 
resistant mutations most likely affect exon B4 of the 
gene COB-BOX. The mutant RNA sequence analysis 
revealed a unique base change in exon B4 relative to the 
wild type which replaces Letrigs by phenylalanine 
(TTA-TTT). Considering the agreement between 
genetic and sequence data, and the fact that the 4 
mutants (independent isolates) carry the same base 
change, demonstrates that this mutation is truly 
responsible for funiculosin resistance. 
Oxygen consumption on isolated mitochondria of 
mutant KL14-4A/funl-210 was much less sensitive to 
funiculosin than the wild type. The concentration of 
funiculosin required for a 50% inhibition was 8 times 
higher for the mutant than for wild type (Fig. 1). No 
difference in antimycin inhibition could be detected 
between mutant and wild type (data not shown). 
4. DISCUSSION 
Four funiculosin-resistant mutations in the 
cytochrome b gene of S. cerevisiae have been 
characterized. These mutants replace a leucine residue 
196 
i 
SC : FALH-YLVPFIIAAMVIMHLMALBIB 
NC: 
A : 
li : 
B : 
M : 
R : 
T : 
Xl : 
Dy: 
2m: 
oe: 
w: 
PC: 
Rc: 
Lr: 
Tb: 
sp: 
FALH-FVLPFILAALVLMELIALHDT 
FALH-FLLPFVLAALALMBLIAMBDT 
FTFH-FILPFIIAALATLELLFLKET 
FAFH-FILPFIIMAIAMVBLLFLBET 
FAFH-FILPFIIAALAIVBLLFLHET 
FAFIi-FILPFIIAALAIVHLLFLBET 
FAFE-FLLPFIIAGASILHLLFLBET 
FAFH-FLLPFIIAGASILWLLFLRET 
FTFH-FILPFIVLAMTMIELLFLHQT 
FSLH-ELLPLILAGASLLELAALHQY 
FSLE-HLLPFILAGASLLELAALHQY 
FSLB-HLLPLILVGASLLELAALBQY 
FSLH-YLLPFVIAALVVVEIWAFBTT 
FSLB-YLLPFVIAALVAIEIWAFBTT 
YSLBTFVLPLLTAIFMLMBFLMIRKQ 
YSLHTFVLPLLTAVFMLYEFPMIRKQ 
YSLATFVLPLLTAVFMLMRFLMIRKQ 
Fig. 2. Amino acid alignments of the wild type cytochrome b (be in 
chloroplasts) region from 18 different species encompassing position 
198 involved in funiculosin resistance in S. cerevikze. SC, S. 
cerevisiae, [37]; NC, Neurospora crassa [38]; A, Aspergillus nidulans 
[39]; H, human [40]; B, bovine [41]; M, mouse [42]; R, rat 1431; Zm, 
Zea mati [44]; Oe, Oenothera [45]; W, wheat [46]; Xl, X. Iaevis [47]; 
Dy, Drosophila yakuba [48]; PC, Paracoccus denitrificans [49]; Rc, 
Rhodobucter capsulutus [50]; Lw, liverwort [51]; Tb, tobacco [52]; 
Sp, spinach [53]. 
by phenylalanine in position 198 of cytochrome b 
polypeptide chain. Funiculosin resistance was express- 
ed in vitro at the level of the mitochondrial respiratory 
chain, whereas no modification in antimycin, diuron or 
mucidin sensitivity could be observed. The mutant 
respiratory activity/growth was nearly the same as the 
wild type. 
Funiculosin-resistant mutants were already localized 
previously in the cytochrome b of S. cerevisiae [20]. 
The mutations mapped to one locus, FUNZ, in the 
fourth exon of the gene COB-BOX [14]. Unfortunate- 
ly, these mutants were lost and could not be sequenced. 
Leucinergs is conserved in all the known mitochon- 
drial cytochrome bs (see Fig. 2). It is replaced in the 
corresponding position by isoleucine in Paracoccus 
denitrijiicans and Rhodobacter capsulatus, and by 
phenylalanine in cytochrome bg of chloroplast, which 
could explain why the b&f complex is insensitive to 
funiculosin. 
Molecular bases for resistance to other bcl complex 
inhibitors have been reported recently [ 12,16,17]. 
Resistance to the center i inhibitors antimycin and 
diuron was found to be conferred upon replacement in 
two regions of the cytochrome b, extending from 
residue 17 to 37 and 225 to 228. Two other regions, 
from residue 129 to 147 and 256 to 275, were shown to 
be involved in binding of the center o inhibitors myx- 
othiazol, mucidin and stigmatellin. The present work 
extends to residue 198, the second center i inhibitor- 
resistant region. 
95 
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According to a folding model for cytochrome b with 
9 transmembrane helices, proposed by Widger et al. 
[211 and Saraste [22], center i as well as center o 
inhibitor-resistant mutations would be located on both 
sides of the membrane (Fig. 3). As already stressed in 
[12,17], the separation of the two center i and the two 
center o inhibitor-resistant regions on opposite sides of 
the membrane seems to be inconsistent with their possi- 
ble belonging to a common structure. The withdrawal 
from the membrane of helix IV of the Widger/Saraste 
model has been proposed from other calculations 
[23-251. According to the resulting 8 helix model, the 
two center i inhibitor-resist~t regions would be located 
on the same side of the membrane (presumed elec- 
tronegative side), whereas the two center o inhibitor- 
resistant regions would belong to the opposite side 
(electropositive) (Fig. 3). Most of the mutations would 
affect extramembrane segments, the few mutations 
buried in the membrane being near the interface. This 
seems to be consistent with two quinone binding sites 
on opposite sides of the membrane where the inhibitors 
would exert their action. 
Despite their common ability of biocking the same 
reaction (reoxidation of heme &Z by ubiquinone) an- 
timycin, diuron and funiculosin have no evident struc- 
tural homology in common. They differ also in some of 
their effects: funiculosin and diuron, for example, do 
not induce, as does antimycin, a red shift in the reduced 
spectrum of heme bs62 [18,55]. This implies some 
specificity in inhibitor binding which is likely responsi- 
ble for the mutant alteration and phenotype specificity 
([12,16,17], this work). The funiculosin-resistant muta- 
tion (leuciner9s into phenylalanine), for example, does 
not modify the sensitivity to diuron or antimycin. 
However, some lines of evidence indicate that the 
center i inhibitor binding sites might overlap or interact 
partially with each other. Some mutations interfere 
with several inhibitors: the antimycin-resistant muta- 
tion anal-Gla (glycines, into valine) confers a weak but 
sig~fic~t increased tolerance to fu~~ulosi~ [17,201; 
the diuron-resist~t mutants are cross resistant in vitro 
to HQNO [18]. Moreover, antimycin displaces HQNO 
from its binding site [26,27] and diuron reverses the red 
shift induced by HQNO [ 181. Finally, the sequence data 
Fig. 3. Cytochrome b structure in the inner mit~hond~al membrane. The 8 a-helix model is that of Widger et al. [21] and Saraste 1221 after 
the withdrawal of helix IV according to Di Rago and Colson [17]. Amino acids involved in inhibitor-resistant mutants are shown in white 
surrounded by a black circle: ANA, antimycin; DIU, diuron; MYX, myxothiazol; MUC, mucidin; STI, stigmatellin [12,16,17] and FUN, 
funiculosin (this work). Numbers in subscript are the amino acid position. P and N represent, respectively, presumed positively and negatively 
charged sides of the inner mitochondrial membrane. 
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([12,16,17], this work) reveal that all the corresponding 
mutations are clustered in two regions which appear to 
belong to the same side, i.e. the inner side of the 
mitochondrial membrane. 
From the bacterial photosynthetic reaction center 
and its chloroplastic counterpart, the photosystem II, it 
might be supposed that this inhibitor-resistant domain 
could be involved in binding of ubiquinone at center i 
of the bci complex. It has been known for some time 
that the QB ubiquinone (plastoquinone) reducing site 
of the reaction center is blocked by competitive binding 
of several inhibitors or herbicides, among them diuron 
[28,29]. Herbicide-resistance was found to be conferred 
upon replacement in the ubiquinone (plastoquinone) 
QB binding subunit (subunit L in photosynthetic 
bacteria [30,31], Dl in photosystem II of chloroplasts 
132-341). From the X-ray structure of the 
Rhodopseudomonas viridis and Rhodobacter 
sphaeroides reaction centers, it appears that the muta- 
tions belong to the QB binding domain [35,36,54]. 
It is tempting by analogy, to assume that the center 
i inhibitor-resistant mutations would belong to a com- 
mon structure overlapping or interacting with the 
center i ubiquinone binding site. This view is enhanced 
by the present work which shows that funiculosin 
resistance is conferred upon replacement beside 
histidineig,, which is thought to be involved in binding 
of the heme b562, the presumed reductant of ubi- 
quinone at center i. 
In the absence of the X-ray structure of the bcl com- 
plex, this mutational analysis provides, thus, insight in- 
to the cytochrome b structure in the membrane and 
defines regions of the protein which might belong to the 
quinone reaction domains of the bcl complex. 
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